Correspondence 0001493152-23-042929 from Aimei Health Technology Co., Ltd. (AFJK)
Aimei Health Technology Co., Ltd.
Date: Nov. 28, 2023 · CIK: 0001979005 · Accession: 0001493152-23-042929
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272230
Letter
November 28, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
F Street, N.E.
Mail Stop 4631
Washington, DC 20549
Attn: Ronald (Ron) E. Alper
Pam Long
Re: Aimei Health Technology Co., Ltd
Request for Acceleration of Registration Statement on Form S-1, as amended
Filed October 27, 2023 File 333-272230
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Spartan Capital Securities, LLC, as representative of the underwriters, hereby joins Aimei Health Technology Co., Ltd in requesting acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4 pm, Eastern Time, on November 30, 2023, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated October 27, 2023, to selected dealers, institutions and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Spartan Capital Securities, LLC
By: /s/ Kim Monchik
Name: Kim Monchik
Title: Chief Administrative Officer
Show Raw Text
CORRESP
1
filename1.htm
November
28, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Manufacturing
100
F Street, N.E.
Mail
Stop 4631
Washington,
DC 20549
Attn:
Ronald
(Ron) E. Alper
Pam
Long
Re:
Aimei
Health Technology Co., Ltd
Request
for Acceleration of Registration Statement on Form S-1, as amended
Filed
October 27, 2023 File 333-272230
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended, Spartan Capital Securities, LLC, as representative of the underwriters, hereby joins Aimei Health Technology Co., Ltd in requesting
acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4 pm, Eastern Time,
on November 30, 2023, or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Securities Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated
October 27, 2023, to selected dealers, institutions and others as appears to be reasonable to secure adequate distribution of the Preliminary
Prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended,
in connection with the above-referenced issue.
Spartan
Capital Securities, LLC
By:
/s/
Kim Monchik
Name:
Kim
Monchik
Title:
Chief
Administrative Officer